NO20084924L - N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer - Google Patents
N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorerInfo
- Publication number
- NO20084924L NO20084924L NO20084924A NO20084924A NO20084924L NO 20084924 L NO20084924 L NO 20084924L NO 20084924 A NO20084924 A NO 20084924A NO 20084924 A NO20084924 A NO 20084924A NO 20084924 L NO20084924 L NO 20084924L
- Authority
- NO
- Norway
- Prior art keywords
- gsk
- thiazolyl
- inhibitors
- amide derivatives
- novel compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06380099A EP1849785A1 (fr) | 2006-04-28 | 2006-04-28 | Dérivés de N-(2-Thiazolyl)-amide en tant qu'inhibiteurs de GSK-3 |
US87838607P | 2007-01-04 | 2007-01-04 | |
PCT/EP2007/054188 WO2007125110A1 (fr) | 2006-04-28 | 2007-04-27 | Utilisation de dérivés de n-(2-thiazolyl)-amides en tant qu'inhibiteurs de la gsk-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084924L true NO20084924L (no) | 2008-11-24 |
Family
ID=38069119
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084924A NO20084924L (no) | 2006-04-28 | 2008-11-24 | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer |
NO20084923A NO20084923L (no) | 2006-04-28 | 2008-11-24 | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084923A NO20084923L (no) | 2006-04-28 | 2008-11-24 | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer |
Country Status (18)
Country | Link |
---|---|
US (2) | US20090221647A1 (fr) |
EP (3) | EP1849785A1 (fr) |
JP (2) | JP2009535321A (fr) |
KR (2) | KR20090015940A (fr) |
CN (2) | CN101432283A (fr) |
AR (1) | AR060675A1 (fr) |
AU (2) | AU2007245624A1 (fr) |
BR (2) | BRPI0711080A2 (fr) |
CA (2) | CA2650326A1 (fr) |
IL (2) | IL194932A0 (fr) |
MA (2) | MA30419B1 (fr) |
MX (2) | MX2008013764A (fr) |
NO (2) | NO20084924L (fr) |
NZ (2) | NZ572840A (fr) |
RU (2) | RU2450000C2 (fr) |
UY (1) | UY30312A1 (fr) |
WO (2) | WO2007125109A1 (fr) |
ZA (1) | ZA200809954B (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR063028A1 (es) | 2006-10-06 | 2008-12-23 | Banyu Pharma Co Ltd | Derivados heterociclicos de piridin-2-carboxamida activadores de glucoquinasas, utiles para el tratamiento de diabetes y obesidad y composiciones farmaceuticas que los contienen. |
ES2445791T3 (es) | 2006-10-21 | 2014-03-05 | Abbvie Deutschland Gmbh & Co Kg | Compuestos hetererocíclicos y su uso como inhibidores de la glucógeno sintasa cinasa 3 |
EP2020232A1 (fr) | 2007-08-03 | 2009-02-04 | Zeltia, S.A. | Dérives de N-(1-thiazolyl)-amide pour traiter l'obésité, le diabète et des maladies cardiovasculaires |
EP2025674A1 (fr) | 2007-08-15 | 2009-02-18 | sanofi-aventis | Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament |
AU2010226857B2 (en) | 2009-03-20 | 2016-07-14 | University Of Virginia Patent Foundation | Broad spectrum benzothiophene-nitrothiazolide and other antimicrobials |
WO2011107494A1 (fr) | 2010-03-03 | 2011-09-09 | Sanofi | Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation |
WO2011157827A1 (fr) | 2010-06-18 | 2011-12-22 | Sanofi | Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases |
US8530413B2 (en) | 2010-06-21 | 2013-09-10 | Sanofi | Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments |
TW201215388A (en) | 2010-07-05 | 2012-04-16 | Sanofi Sa | (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments |
TW201215387A (en) | 2010-07-05 | 2012-04-16 | Sanofi Aventis | Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament |
TW201221505A (en) | 2010-07-05 | 2012-06-01 | Sanofi Sa | Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament |
WO2012040170A2 (fr) * | 2010-09-20 | 2012-03-29 | University Of Virginia Patent Foundation | Compositions et méthodes de traitement de la tuberculose |
JP5998142B2 (ja) | 2010-09-27 | 2016-09-28 | アボット ゲーエムベーハー ウント カンパニー カーゲー | 複素環化合物およびグリコーゲンシンターゼキナーゼ−3阻害薬としてのその使用 |
US9090592B2 (en) | 2010-12-30 | 2015-07-28 | AbbVie Deutschland GmbH & Co. KG | Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors |
WO2012120052A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation |
EP2683700B1 (fr) | 2011-03-08 | 2015-02-18 | Sanofi | Dérivés d'oxathiazine tétra-substitués, leur procédé de fabrication, leur utilisation comme médicament ainsi que médicaments en étant pourvu et leur utilisation |
US8828995B2 (en) | 2011-03-08 | 2014-09-09 | Sanofi | Branched oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof |
EP2683705B1 (fr) | 2011-03-08 | 2015-04-22 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
WO2012120055A1 (fr) | 2011-03-08 | 2012-09-13 | Sanofi | Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation |
WO2013037390A1 (fr) | 2011-09-12 | 2013-03-21 | Sanofi | Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase |
WO2013045413A1 (fr) | 2011-09-27 | 2013-04-04 | Sanofi | Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase |
EP2682119A1 (fr) * | 2012-07-03 | 2014-01-08 | Université Libre de Bruxelles | Dérivés N-hétérocycles aromatiques à utiliser comme médicament |
ES2514093B1 (es) * | 2013-03-25 | 2015-08-17 | Consejo Superior De Investigaciones Cientificas (Csic) | Compuestos neurogénicos basados en melatonina y su uso en el tratamiento de enfermedades del sistema nervioso |
CA3067075A1 (fr) * | 2017-06-14 | 2018-12-20 | European Molecular Biology Laboratory | Composes amide heteroaromatiques bicycliques destines a etre utilises en therapie |
US20230020507A1 (en) * | 2019-10-04 | 2023-01-19 | Parenchyma Biotech Inc. | Compound and use thereof in treating autoimmune diseases |
KR102547762B1 (ko) * | 2019-10-04 | 2023-06-26 | 파렌키마바이오텍 주식회사 | 신규 화합물 및 이의 자가면역질환 치료 용도 |
KR102576382B1 (ko) * | 2022-06-21 | 2023-09-12 | 파렌키마바이오텍 주식회사 | 신규 화합물 및 이의 자가면역질환 치료 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1212326A (en) * | 1969-06-18 | 1970-11-11 | Parke Davis & Co | New 5-nitro-4-thiazoline-3-acetamide compounds and methods for their production |
EP0566138B1 (fr) * | 1992-04-17 | 1998-11-18 | Hodogaya Chemical Co., Ltd. | Amino thiazoles et leur utilisation comme fongicides |
GB9823871D0 (en) * | 1998-10-30 | 1998-12-23 | Pharmacia & Upjohn Spa | 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents |
AU2010601A (en) * | 1999-12-16 | 2001-07-03 | Novartis Ag | Organic compounds |
WO2001056567A1 (fr) * | 2000-02-04 | 2001-08-09 | Novo Nordisk A/S | Derives de 2,4-diaminothiazole |
EP1256578B1 (fr) * | 2001-05-11 | 2006-01-11 | Pfizer Products Inc. | Dérivés de thiazole et leur utilisation comme inhibiteurs de cdk |
CN100357283C (zh) * | 2002-04-02 | 2007-12-26 | 中国科学院上海药物研究所 | 一类甲硫氨酰氨肽酶抑制剂 |
SE0201194D0 (sv) * | 2002-04-19 | 2002-04-19 | Astrazeneca Ab | New compounds |
JP4390704B2 (ja) * | 2002-10-03 | 2009-12-24 | エフ.ホフマン−ラ ロシュ アーゲー | グルコキナーゼ(gk)活性化物質としてのインドール−3−カルボキシアミド |
US6737382B1 (en) * | 2002-10-23 | 2004-05-18 | Nippon Soda Co. Ltd. | Insecticidal aminothiazole derivatives |
WO2005014591A1 (fr) * | 2003-07-15 | 2005-02-17 | L'oreal | 2-acylamino ou 2-sulfonylamino-1, 3-thiazoles en tant qu'agents de couplage pour la coloration d'oxydation de fibres keratiniques |
CN100545161C (zh) * | 2003-08-15 | 2009-09-30 | 中国科学院上海药物研究所 | 一类杂环衍生物、制备方法及其用途 |
EP1532980A1 (fr) | 2003-11-24 | 2005-05-25 | Novo Nordisk A/S | Carboxamides d'indole n-heteroarylé et leurs analogues, utiles comme des activateurs de glucokinase pour le traitement de diabetes |
-
2006
- 2006-04-28 EP EP06380099A patent/EP1849785A1/fr not_active Withdrawn
-
2007
- 2007-04-27 RU RU2008146995/04A patent/RU2450000C2/ru not_active IP Right Cessation
- 2007-04-27 NZ NZ572840A patent/NZ572840A/en not_active IP Right Cessation
- 2007-04-27 JP JP2009507097A patent/JP2009535321A/ja not_active Ceased
- 2007-04-27 UY UY30312A patent/UY30312A1/es not_active Application Discontinuation
- 2007-04-27 KR KR1020087029033A patent/KR20090015940A/ko not_active Application Discontinuation
- 2007-04-27 JP JP2009507096A patent/JP2009535320A/ja active Pending
- 2007-04-27 MX MX2008013764A patent/MX2008013764A/es not_active Application Discontinuation
- 2007-04-27 BR BRPI0711080-4A patent/BRPI0711080A2/pt not_active IP Right Cessation
- 2007-04-27 MX MX2008013765A patent/MX2008013765A/es not_active Application Discontinuation
- 2007-04-27 WO PCT/EP2007/054187 patent/WO2007125109A1/fr active Application Filing
- 2007-04-27 NZ NZ572790A patent/NZ572790A/en not_active IP Right Cessation
- 2007-04-27 EP EP07728641A patent/EP2019828A1/fr not_active Withdrawn
- 2007-04-27 CA CA002650326A patent/CA2650326A1/fr not_active Abandoned
- 2007-04-27 CN CNA2007800154258A patent/CN101432283A/zh active Pending
- 2007-04-27 CN CNA2007800154050A patent/CN101432282A/zh active Pending
- 2007-04-27 US US12/298,861 patent/US20090221647A1/en not_active Abandoned
- 2007-04-27 US US12/298,866 patent/US20090192204A1/en not_active Abandoned
- 2007-04-27 EP EP07728642A patent/EP2019829A1/fr not_active Withdrawn
- 2007-04-27 BR BRPI0711078-2A patent/BRPI0711078A2/pt not_active IP Right Cessation
- 2007-04-27 AU AU2007245624A patent/AU2007245624A1/en not_active Abandoned
- 2007-04-27 AR ARP070101833A patent/AR060675A1/es not_active Application Discontinuation
- 2007-04-27 RU RU2008146993/04A patent/RU2429237C2/ru not_active IP Right Cessation
- 2007-04-27 KR KR1020087029034A patent/KR20090023585A/ko not_active Application Discontinuation
- 2007-04-27 AU AU2007245625A patent/AU2007245625B2/en not_active Ceased
- 2007-04-27 WO PCT/EP2007/054188 patent/WO2007125110A1/fr active Application Filing
- 2007-04-27 CA CA002650323A patent/CA2650323A1/fr not_active Abandoned
-
2008
- 2008-10-27 IL IL194932A patent/IL194932A0/en unknown
- 2008-10-27 IL IL194937A patent/IL194937A0/en unknown
- 2008-11-20 MA MA31393A patent/MA30419B1/fr unknown
- 2008-11-20 MA MA31392A patent/MA30418B1/fr unknown
- 2008-11-24 NO NO20084924A patent/NO20084924L/no not_active Application Discontinuation
- 2008-11-24 ZA ZA2008/09954A patent/ZA200809954B/en unknown
- 2008-11-24 NO NO20084923A patent/NO20084923L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20084924L (no) | N-(2-thiazolyl)-amid derivater som GSK-3 inhibitorer | |
NO20084850L (no) | MGLUR5 modulatorer I | |
NO20090628L (no) | Pyridizinon derivativater | |
DK2024352T3 (da) | Glucopyranosylsubstituerede benzoenitrilderivater, farmaceutiske sammensætninger indeholdende sådanne forbindelser, deres anvendelse og fremgangsmåde for deres fremstilling | |
NO20073791L (no) | Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer | |
NO20074275L (no) | 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister | |
NO20084852L (no) | MGLUR5 modulatorer V | |
NO20084418L (no) | Azolopyridin-3-on derivater som inhibitorer av endoteliallipase | |
NO20083427L (no) | Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse | |
NO20092412L (no) | Hydantoinderivater anvendes som MMP-inhibitorer | |
NO20091395L (no) | Nye tiofenderivater | |
NO20076648L (no) | Novel thiophene derivatives | |
UY32062A (es) | Inhibidores de beta-secretasa | |
NO20081217L (no) | Nye benzotiazolonderivater | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
NO20085121L (no) | Benzimidazolderivater, deres fremstillingsmate, deres anvendelse som FXR-agonister og farmasoytiske blandinger inneholdende samme | |
NO20081729L (no) | Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer | |
NO20083057L (no) | Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer | |
NO20091626L (no) | MGLUR5-modulatorer | |
CL2007000918A1 (es) | Compuestos derivados de enfumafungina, inhibidores de (1,3)-beta-d-glucanosintetasa; composicion farmaceutica; y uso para tratar una infeccion fungica. | |
NO20073572L (no) | Nye forbindelser | |
NO20080394L (no) | N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
NO20084301L (no) | Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler | |
NO20085052L (no) | 4-((fluorofenoksyl)fenylmetyl)piperidin metansulfonat: anvendelser, synteseprosess og farmasoytiske sammensetninger |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |